Veraxa Biotech AG VRXA

Full chart Compare
Set alert

Price alert · VRXA

All alert types
0.99 USD -0.04 (-3.88%)

At closeNov 3, 2026, 4:00 PM EST

0.99 0.00 0.00%

After hours · Nov 3, 4:00 PM ET

0.9623 Day range 1.06
0.95 52-week range 27.36
YTD
-90.72%
1 year
-90.56%

Revenue & Expenses

Income Tax Benefit → Expenses: $392.60KExpenses → Selling, General & Admin: $53.87MExpenses → Research & Development: $10.26MExpenses → Other Operating Expenses: $2.10MExpenses → Interest Expense: $3.55KExpenses → Other Expenses: $786.47KGross Profit → Expenses: $15.46KRevenue → Gross Profit: $15.46KRevenue → Cost of Revenue: $7.96KNet Loss → Expenses: $66.61MIncome Tax Benefit$392.60KGross Profit$15.46KNet Loss$66.61MCost of Revenue$7.96KExpenses$67.02MSelling, General & Admin$53.87MResearch & Development$10.26MOther Operating Expenses$2.10MInterest Expense$3.55KOther Expenses$786.47KRevenue$23.43K

Latest period ending Dec 31, 2025 · select a line to chart its full history

Annual income statement

VRXA annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024
23.43K0
29.65K0
7.96K0
15.46K0
66.23M28.92M
10.26M6.31M
53.87M20.73M
-66.22M-28.92M
3.55K291
-392.60K-620.77K
-66.61M-28.13M
-66.61M-28.13M
-84.32M-31.26M
-66.61M-28.13M
-4.60-2.00
-5.82-2.22
-4.60-2.00
-67.00M-28.75M
-84.81M-31.95M
14.47M14.05M
14.47M14.05M